The emergence of 'omics for the management of colorectal cancer.

The emergence of 'omics for the management of colorectal cancer.

PURPOSE OF REVIEW: The past couple of years have seen a flurry of publications detailing potential prognostic and predictive biomarkers for colorectal cancer. However, most studies have been underpowered and demonstrate elements of a statistical 'fishing exercise', that is the carrying ou...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Midgley, R, Church, D, Kerr, D
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2011

Míreanna comhchosúla

Biomarkers in early-stage colorectal cancer: ready for prime time?
de réir: Church, D, et al.
Foilsithe / Cruthaithe: (2012)

Immunotherapy for colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2003)

Colorectal cancer.
de réir: Nicum, S, et al.
Foilsithe / Cruthaithe: (2003)

Colorectal cancer
de réir: Nicum, S, et al.
Foilsithe / Cruthaithe: (2003)

Adjuvant therapy of colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Chemotherapy for colorectal cancer.
de réir: Nicum, S, et al.
Foilsithe / Cruthaithe: (2000)

ABC of colorectal cancer: adjuvant therapy.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Towards post-genomic investigation of colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2000)

Conventional cytotoxic and novel therapeutic concepts in colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2001)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2005)

Immunotherapy for colorectal cancer: a challenge to clinical trial design.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2000)

Evolution of nonsurgical therapy for colorectal cancer.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2009)

Regional Hepatic Chemotherapies in the Treatment of Colorectal Cancer Metastases to the Liver
de réir: Pwint, T, et al.
Foilsithe / Cruthaithe: (2010)

Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
de réir: Pwint, T, et al.
Foilsithe / Cruthaithe: (2010)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2005)

Systemic treatment of colorectal cancer.
de réir: Tebbutt, N, et al.
Foilsithe / Cruthaithe: (2002)

Are NSAIDs Coming Back to Colorectal Cancer Therapy or Not?
de réir: Herbert, K, et al.
Foilsithe / Cruthaithe: (2014)

Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer
de réir: Church, D, et al.
Foilsithe / Cruthaithe: (2013)

Colorectal Cancer: A Multidisciplinary Approach
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2012)

Genetic prognostic and predictive markers in colorectal cancer.
de réir: Walther, A, et al.
Foilsithe / Cruthaithe: (2009)

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
de réir: Domingo, E, et al.
Foilsithe / Cruthaithe: (2013)

Erratum: Genetic prognostic and predictive markers in colorectal cancer (Nature Reviews Cancer (2009) 9 (489-499))
de réir: Walther, A, et al.
Foilsithe / Cruthaithe: (2011)

COLORECTAL CANCER
de réir: Kerr, D
Foilsithe / Cruthaithe: (2010)

Ras as a target in cancer therapy.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2002)

Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2010)

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2010)

Adjuvant chemotherapy for colorectal cancer.
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (1996)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
de réir: Midgley, R, et al.
Foilsithe / Cruthaithe: (2013)

Can we treat cancer for a dollar a day? Guidelines for low-income countries.
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2010)

Can we treat cancer for a dollar a day? Guidelines for low-income countries
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2010)

The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy.
de réir: Grumett, SA, et al.
Foilsithe / Cruthaithe: (2001)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
de réir: Maosen Huang, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Cancer of the Colon and Rectum: Treatment: Chemotherapy
de réir: Sabharwal, A, et al.
Foilsithe / Cruthaithe: (2009)

Can we individualize chemotherapy for colorectal cancer?
de réir: Chan, R, et al.
Foilsithe / Cruthaithe: (2004)

VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
de réir: Kerr, D, et al.
Foilsithe / Cruthaithe: (2008)

Integrated multi-omics characterization of SMAD4 mutant colorectal cancer
de réir: Danyi Zhao, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
de réir: YuanLin Sun, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Capecitabine/irinotecan combination regimens in colorectal cancer.
de réir: Kerr, D
Foilsithe / Cruthaithe: (2002)